StockMacro
Company, fund or insider

Help

Menu

Ascendis Pharma A/S Ordinary Share

ASND on XNAS

Measures activity, not value. Not investment advice.

Latest month (Feb 2026)

$30.1

Last 12 months

$210K

vs the 12 months before

Sharp changes

0

federal obligations jump, first federal award, first award from a new federal agency

Window
Record type

What usually follows Federal contracts growth was not followed by a clear share-price difference over the next 6 months. No relationship found How we measured it

Federal obligations: $30.1 in February 2026

USAspending.gov obligations by date. Dashed: 3-year median.

See the numbers
Month of Feb 2026: $30.1
Month of Jul 2025: $210K

What the numbers say

  • Federal obligations: $30.1 in February 2026.

Every measure from this source

5 years, by the period each figure describes

Obligations (contracts + grants). $30.1 in the latest period.
Contract obligations. $30.1 in the latest period.
New awards. 0 in the latest period.

Sharp changes

0 in all loaded history, strongest first

No sharp change of this kind in all loaded history.

The records

Newest first, by the day each became public

No records in all loaded history with these filters.